49 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Treating Acute Infection ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
less than 200 cells ... Antimicrobial treatment ... status, and focal neurologic ... confusion, and focal neurologic ... InfectiousDiseases #Neurology
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
C virus (HCV) infection ... DAAs #Antivirals #table ... #treatment #hcv ... infectiousdisease #hepatology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... of mode of HIV infection ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection in HIV-AIDS ... Infection General ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... for effective treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... Clostridium difficile Infection ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
with positive serology ... CD4 count <250 cells ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Activation of CD8 T cells ... Phagocytosis of blood cells ... Unknown cause Treatment ... diagnosis #management #treatment ... #summary #rheumatology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
CD4 count <200 cells ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS